Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Jain, Mumbai
Arun Kumar Jain, Mumbai IN
| Patent application number | Description | Published |
|---|---|---|
| 20100267690 | TRICYCLIC GUANIDINE DERIVATIVES AS SODIUM-PROTON EXCHANGE INHIBITORS - Guanidine derivatives having a condensed tricyclic ring of formula 1: | 10-21-2010 |
Ashok Kundanmal Jain, Mumbai IN
| Patent application number | Description | Published |
|---|---|---|
| 20110045978 | HERBICIDAL FORMULATION - This invention relates to an improved granular formulation of herbicide glyphosate in form of ammonium salt using environmentally friendly adjuvants, and a process for preparation thereof. The formulation minimizes the use of some inactive ingredients without compromising the effectiveness of the product. | 02-24-2011 |
Ashwin Kumar Jain, Mumbai IN
| Patent application number | Description | Published |
|---|---|---|
| 20100180563 | EASILY ALKALI SOLUBLE POLYESTER AND METHOD FOR PRODUCING THE SAME - The present invention discloses an easily alkali soluble polyester comprising at least one dicarboxylic acid or monoesters thereof or diesters thereof; at least one diol; at least one carboxylic acid anhydride; at least one sodium or lithium based aromatic co-monomer and at least one hydroxyl terminated polyester polyol. The polyester is produced by esterifying at least one dicarboxylic acid or monoesters thereof or diesters thereof and at least one diol alongwith at least one acid anhydride at a temperature in the range of 250 to 290° C. and pressure in the range of 0 to 5 kg/cm | 07-22-2010 |
Hiteshkumar D. Jain, Mumbai IN
| Patent application number | Description | Published |
|---|---|---|
| 20100261711 | SELECTIVE ANTICONVULSANT AGENTS AND THEIR USES - In preferred embodiments, the present invention provides methods of treatment and pharmaceutical compositions for the suppression, alleviation and prevention of seizures. The preferred embodiments of the present invention further relate to methods of treatment and pharmaceutical compositions using benzodiazepine derivatives that provide suppression, alleviation and prevention of seizures with reduced sedative and ataxic side effects. | 10-14-2010 |
Paras R. Jain, Mumbai IN
| Patent application number | Description | Published |
|---|---|---|
| 20090053310 | NOVEL SUSTAINED RELEASE DOSAGE FORM - The novel sustained release dosage form comprising an active agent and a combination of a non-swelling pH dependent release retardant and a non swelling pH independent release retardant polymer which provides pH-independent drug release for a considerable period of time after administration. | 02-26-2009 |
| 20090123543 | PHARMACEUTICAL COMPOSITIONS - A novel solid oral dosage form comprising a therapeutically effective amount of hydrophobic pharmacological active ingredient and at least one particle separating agent preferably selected from a class of wetting agents, prepared without or with minimum amount of a disintegrating agent. The hydrophobic pharmacological active ingredient active ingredient belongs to the class of angiotensin receptor blocking agents preferably is valsartan optionally in combination with hydrochlorothiazide. The active ingredient may also be a class of 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase inhibitors preferably atorvastatin. The ratio of hydrophobic active ingredient to particle separating agent is about 20:1 to about 1:20. The process for the preparation of the novel solid oral dosage form comprises treating a hydrophobic active ingredient with at least one particle separating agent, and incorporating the treated hydrophobic active ingredient into a solid dosage form. | 05-14-2009 |
| 20100119607 | BIOENHANCED COMPOSITIONS - The present invention relates to the method of increasing the bioavailability of Angiotensin II Receptor Blockers (ARBs) by preparing a composition of an ARB with at least one solubility enhancing agent. The invention is particularly focused to provide a novel or modified dissolution profile where the release of ARB in the GI tract is independent of physiological pH conditions. | 05-13-2010 |
Sanjay Kumar Ramesh Kumar Jain, Mumbai IN
| Patent application number | Description | Published |
|---|---|---|
| 20100270577 | PLASTIC COMPONENT FOR A LIGHTING SYSTEMS - The invention relates to a plastic component for use in a lighting system, the plastic component comprising a semi-aromatic polyamide (X) comprising repeat units derived from aliphatic diamines and dicarboxylic acids wherein: (a) the aliphatic diamines consist a mixture of 10-70 mole % of a short chain aliphatic diamine with 2-5 C atoms and 30-90 mole % of a long chain aliphatic diamine with at least 6 C atoms; (b) the dicarboxylic acids consist of a mixture of 5-65 mole % aliphatic dicarboxylic acid and optionally aromatic dicarboxylic acid other than terephthalic acid, and 35-95 mole % terephthalic acid; and (c) the combined molar amount of terephthalic acid and the long chain aliphatic diamine is at least 60 mole %, relative to the total molar amount of the dicarboxylic acids and diamines. The invention also relates to a polymer composition that can be used for making the said plastic component comprising 100 pbw of a semi-aromatic polyamide (X) and 1-250 pbw of an inorganic material. | 10-28-2010 |